178 related articles for article (PubMed ID: 34930182)
21. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Namane T; Mpholo T; Battegay M; Klimkait T; Labhardt ND
PLoS Med; 2020 Sep; 17(9):e1003325. PubMed ID: 32936795
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness and cost-effectiveness of 3- vs. 6-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART-refill groups in Zimbabwe: study protocol for a pragmatic, cluster-randomized trial.
Fatti G; Ngorima-Mabhena N; Chirowa F; Chirwa B; Takarinda K; Tafuma TA; Mahachi N; Chikodzore R; Nyadundu S; Ajayi CA; Mutasa-Apollo T; Mugurungi O; Mothibi E; Hoffman RM; Grimwood A
Trials; 2018 Jan; 19(1):79. PubMed ID: 29378662
[TBL] [Abstract][Full Text] [Related]
23. Protocol for an evaluation of adherence monitoring and support interventions among people initiating antiretroviral therapy in Cape Town, South Africa-a multiphase optimization strategy (MOST) approach using a fractional factorial design.
Jennings L; West RL; Halim N; Kaiser JL; Gwadz M; MacLeod WB; Gifford AL; Haberer JE; Orrell C; Sabin LL
Trials; 2023 May; 24(1):310. PubMed ID: 37147725
[TBL] [Abstract][Full Text] [Related]
24. Point-of-care viral load testing among adolescents and youth living with HIV in Haiti: a protocol for a randomised trial to evaluate implementation and effect.
Reif LK; Belizaire ME; Seo G; Rouzier V; Severe P; Joseph JM; Joseph B; Apollon S; Abrams EJ; Arpadi SM; Elul B; Pape JW; McNairy ML; Fitzgerald DW; Kuhn L
BMJ Open; 2020 Aug; 10(8):e036147. PubMed ID: 32868354
[TBL] [Abstract][Full Text] [Related]
25. A Sequential Multiple Assignment Randomized Trial of scalable interventions for ART delivery in South Africa: the SMART ART study.
van Heerden A; Szpiro A; Ntinga X; Celum C; van Rooyen H; Essack Z; Barnabas R
Trials; 2023 Jan; 24(1):32. PubMed ID: 36647092
[TBL] [Abstract][Full Text] [Related]
26. Provision of HIV viral load testing services in Zimbabwe: Secondary data analyses using data from health facilities using the electronic Patient Monitoring System.
Apollo T; Takarinda KC; Phillips A; Ndhlovu C; Cowan FM
PLoS One; 2021; 16(1):e0245720. PubMed ID: 33481931
[TBL] [Abstract][Full Text] [Related]
27. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
28. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
[TBL] [Abstract][Full Text] [Related]
29. Clinic-based SAMBA-II vs centralized laboratory viral load assays among HIV-1 infected children, adolescents and young adults in rural Zimbabwe: A randomized controlled trial.
Kouamou V; Machekano R; Mapangisana T; Maposhere C; Mutetwa R; Manasa J; Shamu T; McCarty K; Munyati S; Mutsvangwa J; Bogoshi M; Israelski D; Katzenstein D
PLoS One; 2023; 18(2):e0281279. PubMed ID: 36787296
[TBL] [Abstract][Full Text] [Related]
30. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
Hermans LE; Moorhouse M; Carmona S; Grobbee DE; Hofstra LM; Richman DD; Tempelman HA; Venter WDF; Wensing AMJ
Lancet Infect Dis; 2018 Feb; 18(2):188-197. PubMed ID: 29158101
[TBL] [Abstract][Full Text] [Related]
31. The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection.
Paton NI; Stöhr W; Oddershede L; Arenas-Pinto A; Walker S; Sculpher M; Dunn DT
Health Technol Assess; 2016 Mar; 20(21):1-158. PubMed ID: 26986803
[TBL] [Abstract][Full Text] [Related]
32. Monitoring diagnosis, retention in care and viral load suppression in children testing HIV polymerase chain reaction-positive in two districts in South Africa.
Moyo F; Haeri Mazanderani A; Feucht UD; Ngoma K; Bhardwaj S; Goosen M; Greyling D; Mhlongo OB; Sherman GG
S Afr Med J; 2019 Aug; 109(9):686-692. PubMed ID: 31635595
[TBL] [Abstract][Full Text] [Related]
33. Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial.
Kuhn L; Coovadia A; Strehlau R; Martens L; Hu CC; Meyers T; Sherman G; Hunt G; Persaud D; Morris L; Tsai WY; Abrams EJ
Lancet Infect Dis; 2012 Jul; 12(7):521-30. PubMed ID: 22424722
[TBL] [Abstract][Full Text] [Related]
34. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
35. More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa.
Fairlie L; Sawry S; Pals S; Sherman G; Williamson D; Le Roux J; Ngeno B; Berrie L; Diallo K; Cox MH; Mogashoa M; Chersich M; Modi S;
J Acquir Immune Defic Syndr; 2023 Dec; 94(5):412-420. PubMed ID: 37949444
[TBL] [Abstract][Full Text] [Related]
36. Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
Schoffelen AF; Wensing AM; Tempelman HA; Geelen SP; Hoepelman AI; Barth RE
PLoS One; 2013; 8(3):e58526. PubMed ID: 23505529
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.
Chung MH; McGrath CJ; Beck IA; Levine M; Milne RS; So I; Andersen N; Dross S; Coombs RW; Chohan B; Yatich N; Kiptinness C; Sakr SR; Kiarie JN; Frenkel LM
Lancet HIV; 2020 Feb; 7(2):e104-e112. PubMed ID: 31818716
[TBL] [Abstract][Full Text] [Related]
38. A packaged intervention to improve viral load monitoring within a deeply rural health district of South Africa.
Brijkumar J; Johnson BA; Zhao Y; Edwards J; Moodley P; Pathan K; Pillay S; Castro KG; Sunpath H; Kuritzkes DR; Moosa MYS; Marconi VC
BMC Infect Dis; 2020 Nov; 20(1):836. PubMed ID: 33176715
[TBL] [Abstract][Full Text] [Related]
39. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
[TBL] [Abstract][Full Text] [Related]
40. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
Maskew M; Brennan AT; Fox MP; Vezi L; Venter WDF; Ehrenkranz P; Rosen S
PLoS Med; 2020 Aug; 17(8):e1003226. PubMed ID: 32853271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
